Enzowid-D Tablet
Images are for reference. Actual packaging may vary.
Trypsin (48mg) + Bromelain (90mg) + Rutoside (100mg) + Diclofenac (50mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+3 more active ingredients
Diclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Bromelain breaks down fibrin and other proteins involved in inflammation, reducing swelling and pain.
Medical applications
Enzowid-D Tablet is a combination pharmaceutical formulation containing Trypsin (48 mg), Bromelain (90 mg), Rutoside (100 mg), and Diclofenac (50 mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins, promoting the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates.
Rutoside, a bioflavonoid, acts as a vascular protector by strengthening capillary walls and reducing capillary permeability, thereby minimizing bruising and swelling. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes (COX-1 and COX-2), resulting in decreased synthesis of prostaglandins, which are mediators of pain and inflammation. The synergistic action of these components makes Enzowid-D effective in managing acute musculoskeletal conditions such as sprains, strains, contusions, and postoperative inflammation.
It is also beneficial in chronic inflammatory disorders where pain and swelling are prominent symptoms. Enzowid-D should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, peptic ulcer disease, and bleeding disorders. Adherence to prescribed dosage and duration is essential to maximize therapeutic benefits while minimizing potential adverse effects.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Enzowid-D Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Information regarding the use of Enzowid-D Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Enzowid-D Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enzowid-D Tablet may not be needed in these patients. Please consult your doctor.
Exercise Caution
Enzowid-D Tablet may cause side effects which could affect your ability to drive. Enzowid-D Tablet may cause headaches, blurred vision, dizziness or drowsiness in some patients. This may affect your ability to drive.
Consult Doctor
Enzowid-D Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Enzowid-D Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Enzowid-D Tablet







